GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Glucose Health GLUC · USD

N/A · US listing · 🇺🇸 United States

Compare

0.30

-3.75%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$340,659

FY2016FY2025

Net income

−$230,702

FY2016FY2025

Free cash flow

−$15,751

FY2016FY2025

Shareholders' equity

$146,795

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$340,659$384,078$534,724$1.1m$953,681$480,713$291,213$197,500$104,522$313,229
Research and development—$5,500————————
Operating income−$199,804−$306,555−$421,953−$562,120−$336,120−$564,360−$230,110−$23,490−$59,840−$86,647
Net income−$230,702−$315,930−$421,953−$562,116−$338,904−$581,443−$246,150−$47,053$24,531−$410,443
Diluted earnings per share-0.01-0.02-0.02-0.04-0.02-0.02-0.01-0.010.00-0.12

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$174,558$322,319$398,772$598,126$1.2m$344,616$219,725$89,235$26,931$33,145
Cash and short-term investments$30,758$26,510$203,879$267,477$752,402$69,150$46,490$20,290$22,405$20,542
Total liabilities$27,762$387,325$141,048$21,036$9,555$303,527$380,652$559,995$459,488$528,592
Debt—$234,375———$112,157$334,657$464,816$373,727$351,827
Shareholders' equity$146,795−$65,005$257,724$577,090$1.1m$41,088−$160,927−$470,759−$432,557−$495,447
Shares outstanding27m17m17m15m14m29m29m6m5m3m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−$15,751−$455,067−$243,785−$389,154−$72,739−$68,937−$234,255−$82,223−$58,136−$39,263
Capital spending—−$18,502−$5−$4—−$3,295————
Free cash flow−$15,751−$473,569−$243,790−$389,158−$72,739−$72,232−$234,255−$82,223−$58,136−$39,263
Dividends paid—−$18,801−$19,813−$95,771−$99,443−$49,607−$16,828——−$49,607

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$38,830$59,823$125,343$58,098$83,955$73,263$60,907$69,376
Operating income−$309,769−$159,822$7,971−$65,060−$75,553−$67,162−$62,913−$96,364
Net income−$309,769−$159,822$9,226−$75,757−$87,723−$72,787−$63,038−$100,114
Diluted earnings per share-0.01-0.010.00-0.00-0.00-0.00-0.00-0.01
Total assets$246,678$202,307$174,558$189,050$237,769$275,347$322,319$369,048
Cash and short-term investments$35,202$51,016$30,758$20,833$22,347$7,194$26,510$102,548
Debt$4,255$2,175—$226,255$215,558$240,000$234,375$228,750
Shareholders' equity$73,625$177,090$146,795−$346,606−$243,899−$165,838−$65,005$17,531

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-31.8%-6.7%54.9%
Operating income-29.2%-18.8%2.5%
Net income-25.7%-16.9%-1.4%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-69.9%-63.9%-63.5%-63.0%
Net margin-75.4%-65.6%-65.1%-72.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-25.2-3.8-6.6-9.5-39.4-170.7-8.5-7.511.8-0.1
Price to sales17.13.15.25.014.0206.57.21.82.80.2

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return99%-64%-61%-51%-56%3790%-5%11%102%1252%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 50-to-1 reverse split · 17 Nov 2014
  • 10-to-1 reverse split · 26 Feb 2014
  • 6-for-5 split · 25 Jun 2010

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.